Cargando…

MRI Radiomic Features to Predict IDH1 Mutation Status in Gliomas: A Machine Learning Approach using Gradient Tree Boosting

In patients with gliomas, isocitrate dehydrogenase 1 (IDH1) mutation status has been studied as a prognostic indicator. Recent advances in machine learning (ML) have demonstrated promise in utilizing radiomic features to study disease processes in the brain. We investigate whether ML analysis of mul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakai, Yu, Yang, Chen, Kihira, Shingo, Tsankova, Nadejda, Khan, Fahad, Hormigo, Adilia, Lai, Albert, Cloughesy, Timothy, Nael, Kambiz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662499/ https://www.ncbi.nlm.nih.gov/pubmed/33121211 http://dx.doi.org/10.3390/ijms21218004

Ejemplares similares

Multiparametric MRI texture analysis in prediction of glioma biomarker status: added value of MR diffusion
por: Kihira, Shingo, et al.
Publicado: (2021)

Multi-Parametric Radiomic Model to Predict 1p/19q Co-Deletion in Patients with IDH-1 Mutant Glioma: Added Value to the T2-FLAIR Mismatch Sign
por: Kihira, Shingo, et al.
Publicado: (2023)

U-Net Based Segmentation and Characterization of Gliomas
por: Kihira, Shingo, et al.
Publicado: (2022)

Tumoral and immune heterogeneity in an anti-PD-1-responsive glioblastoma: a case study
por: Restrepo, Paula, et al.
Publicado: (2020)

Multicenter DSC–MRI-Based Radiomics Predict IDH Mutation in Gliomas
por: Manikis, Georgios C., et al.
Publicado: (2021)

Noninvasive Determination of the IDH Status of Gliomas Using MRI and MRI-Based Radiomics: Impact on Diagnosis and Prognosis
por: Li, Yurong, et al.
Publicado: (2022)

Addition of arterial spin-labelled MR perfusion to conventional brain MRI: clinical experience in a retrospective cohort study
por: Belani, Puneet, et al.
Publicado: (2020)

Widely metastatic glioblastoma with BRCA1 and ARID1A mutations: a case report
por: Umphlett, Melissa, et al.
Publicado: (2020)

Predicting IDH genotype in gliomas using FET PET radiomics
por: Lohmann, Philipp, et al.
Publicado: (2018)

IDH mutation-specific radiomic signature in lower-grade gliomas
por: Liu, Xing, et al.
Publicado: (2019)

Early volumetric, perfusion, and diffusion MRI changes after mutant isocitrate dehydrogenase (IDH) inhibitor treatment in IDH1-mutant gliomas
por: Cho, Nicholas S, et al.
Publicado: (2022)

BIMG-11. PHARMACODYNAMIC EVALUATION OF IDH AND EGFR INHIBITION IN HUMAN GLIOMAS USING MOLECULAR MRI
por: Ellingson, Benjamin, et al.
Publicado: (2021)

Prediction of the Molecular Subtype of IDH Mutation Combined with MGMT Promoter Methylation in Gliomas via Radiomics Based on Preoperative MRI
por: Sha, Yongjian, et al.
Publicado: (2023)

Trans-synaptic degeneration of the optic radiation from optic nerve atrophy
por: Kihira, Shingo, et al.
Publicado: (2021)

Establishment of a Prediction Model Based on Preoperative MRI Radiomics for Diffuse Astrocytic Glioma, IDH-Wildtype, with Molecular Features of Glioblastoma
por: Du, Peng, et al.
Publicado: (2023)

Retrospective examination of pseudoprogression in IDH mutant gliomas
por: Wetzel, Ethan A, et al.
Publicado: (2023)

Mismatch repair protein mutations in isocitrate dehydrogenase (IDH)-mutant astrocytoma and IDH-wild-type glioblastoma
por: Richardson, Timothy E, et al.
Publicado: (2023)

The Value of Enhanced MR Radiomics in Estimating the IDH1 Genotype in High-Grade Gliomas
por: Niu, Lei, et al.
Publicado: (2020)

Forecasting Molecular Features in IDH-Wildtype Gliomas: The State of the Art of Radiomics Applied to Neurosurgery
por: Gerardi, Rosa Maria, et al.
Publicado: (2023)

A Phase I Trial of VEGF-A Inhibition Combined with PD-L1 Blockade for Recurrent Glioblastoma
por: Chiu, Daniel, et al.
Publicado: (2023)

Investigating the value of radiomics stemming from DSC quantitative biomarkers in IDH mutation prediction in gliomas
por: Ioannidis, Georgios S., et al.
Publicado: (2023)

IDH-mutant astrocytoma with EGFR amplification—Genomic profiling in four cases and review of literature
por: Umphlett, Melissa, et al.
Publicado: (2022)

MRI-Based Radiomics Combined with Deep Learning for Distinguishing IDH-Mutant WHO Grade 4 Astrocytomas from IDH-Wild-Type Glioblastomas
por: Hosseini, Seyyed Ali, et al.
Publicado: (2023)

Waist circumference prediction for epidemiological research using gradient boosted trees
por: Zhou, Weihong, et al.
Publicado: (2021)

Identification of cyclin protein using gradient boost decision tree algorithm
por: Zulfiqar, Hasan, et al.
Publicado: (2021)

Feature Importance in Gradient Boosting Trees with Cross-Validation Feature Selection
por: Adler, Afek Ilay, et al.
Publicado: (2022)

Modeling Tick Populations: An Ecological Test Case for Gradient Boosted Trees
por: Manley, William, et al.
Publicado: (2023)

The prognostic impact of subclonal IDH1 mutation in grade 2–4 astrocytomas
por: Vij, Meenakshi, et al.
Publicado: (2023)

Therapies for IDH-Mutant Gliomas
por: Alshiekh Nasany, Ruham, et al.
Publicado: (2023)

Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PET
por: Tatekawa, Hiroyuki, et al.
Publicado: (2021)

Deep Learning based Radiomics (DLR) and its usage in noninvasive IDH1 prediction for low grade glioma
por: Li, Zeju, et al.
Publicado: (2017)

Planning TTFields treatment using the NovoTAL system-clinical case series beyond the use of MRI contrast enhancement
por: Connelly, Jennifer, et al.
Publicado: (2016)

Unveiling YKL-40, from Serum Marker to Target Therapy in Glioblastoma
por: Iwamoto, Fabio M., et al.
Publicado: (2014)

The CNS and the Brain Tumor Microenvironment: Implications for Glioblastoma Immunotherapy
por: Desland, Fiona A., et al.
Publicado: (2020)

Classification of Data from Electronic Nose Using Gradient Tree Boosting Algorithm
por: Luo, Yuan, et al.
Publicado: (2017)

Gradient tree boosting and network propagation for the identification of pan-cancer survival networks
por: Thedinga, Kristina, et al.
Publicado: (2022)

Gradient boosting decision-tree-based algorithm with neuroimaging for personalized treatment in depression
por: Ali, Farzana Z., et al.
Publicado: (2022)

Radiomic study on preoperative multi‐modal magnetic resonance images identifies IDH‐mutant TERT promoter‐mutant gliomas
por: Wang, Haoyu, et al.
Publicado: (2022)

Human IDH mutant 1p/19q co-deleted gliomas have low tumor acidity as evidenced by molecular MRI and PET: a retrospective study
por: Yao, Jingwen, et al.
Publicado: (2020)

Multiregional radiomics profiling from multiparametric MRI: Identifying an imaging predictor of IDH1 mutation status in glioblastoma
por: Li, Zhi‐Cheng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_snbi4em59hbj95fra6dkt3uplm